title: Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers.
abstract: This study was performed in 36 healthy volunteers to define the relationship between plasma concentrations of partially oxidized low density lipoprotein (poxLDL), plasma glucose and insulin responses to oral glucose, and steady-state plasma glucose (SSPG) concentrations after a 180-minute infusion of somatostatin, insulin, and glucose. The concentration of poxLDL was estimated by determining the amount of conjugated dienes formed during in vitro LDL oxidation in the presence or absence of alanine. Under these conditions, the greater the in vitro antioxidant effect of alanine, the lower the amount of poxLDL that was present in plasma. The results demonstrated that plasma poxLDL concentration was significantly correlated with plasma glucose (r=.53, P<.001) and insulin (r=.43, P<.01) responses, SSPG concentrations (r=.53, P<.001), and plasma triglyceride (r=.42, P<.01) and HDL cholesterol (r=-.50, P<.002) concentrations. Furthermore, these relationships persisted when the data were corrected for differences in age, sex, body mass index, and the ratio of waist to hip girth. Of note, there was no correlation between poxLDL and LDL cholesterol concentration. When SSPG was entered along with age, sex, body mass index, and waist-to-hip ratio in a multiple regression model, SSPG alone was a significant prediction of poxLDL (r-=.37, P<.02). The addition of plasma glucose and insulin responses and triglyceride and HDL cholesterol concentrations increased the r2 to only .47. These results show that the amount of poxLDL in plasma is significantly correlated with insulin resistance (ie, SSPG) and its metabolic consequences.
authors.affiliation: Stanford University School of Medicine, CA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Carantoni
authors.forename: F
authors.initials: F
authors.lastname: Abbasi
authors.forename: F
authors.initials: F
authors.lastname: Warmerdam
authors.forename: M
authors.initials: M
authors.lastname: Klebanov
authors.forename: P W
authors.initials: PW
authors.lastname: Wang
authors.forename: Y D
authors.initials: YD
authors.lastname: Chen
authors.forename: S
authors.initials: S
authors.lastname: Azhar
authors.forename: G M
authors.initials: GM
authors.lastname: Reaven
mesh_terms: D000328:Adult; D000368:Aged; D001786:Blood Glucose; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood* / Q000494:pharmacology; D007333:Insulin Resistance; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction
chemical_list: D001786:Blood Glucose; D007328:Insulin; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein